Multifaceted Immune Responses to African Swine Fever Virus: Implications for Vaccine Development

Area of Science:

• Veterinary Virology
• Immunology
• Animal Health

Background:

• African swine fever (ASF) is a highly contagious and lethal viral disease caused by the African swine fever virus (ASFV).
• ASF re-emerged in Europe in 2007 and has since spread across Europe and Asia, posing a significant threat to the global swine industry.
• Currently, no commercial vaccines are available for ASF, hindering effective disease control.

Purpose of the Study:

• To provide an overview of current knowledge on innate and adaptive immune responses to ASFV infection.
• To review various vaccine candidates developed for ASF.
• To discuss the applications, prospects, and implications for rational vaccine design.

Main Methods:

• Literature review of existing research on ASFV-induced immune responses.
• Analysis of data on various ASF vaccine candidates.
• Discussion of scientific challenges and future directions in ASF vaccine development.

Main Results:

• Limited understanding of ASFV-specific immune responses remains a key hurdle in vaccine development.
• Several promising vaccine candidates have been reported, but none have reached commercialization.
• Insights into immune mechanisms are essential for designing effective and safe ASF vaccines.

Conclusions:

• A comprehensive understanding of innate and adaptive immunity to ASFV is critical for successful vaccine development.
• Further research is needed to overcome existing scientific challenges in creating a commercial ASF vaccine.
• The study highlights the importance of immune response mechanisms for the rational design of future ASF vaccines.